{
    "Trade/Device Name(s)": [
        "ALPHA Cryptococcal Antigen EIA",
        "ALPHA Cryptococcal Antigen Enzyme Immunoassay",
        "Cryptococcus Antigen EIA"
    ],
    "Submitter Information": "Immuno-Mycologics, Inc.",
    "510(k) Number": "K120946",
    "Predicate Device Reference 510(k) Number(s)": [
        "K904393"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MDU"
    ],
    "Summary Letter Date": "October 25, 2012",
    "Summary Letter Received Date": "October 26, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3165"
    ],
    "Regulation Name(s)": [
        "Cryptococcus neoformans serological reagents"
    ],
    "Analyte Class(es)": [
        "mycology",
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "Cryptococcus capsular polysaccharide antigen"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Microplate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Direct immunoenzymatic sandwich assay"
    ],
    "Methodologies": [
        "Sandwich EIA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Control",
        "Standard",
        "Microplate"
    ],
    "Document Summary": "FDA 510(k) summary for ALPHA Cryptococcal Antigen EIA, a microplate immunoassay for detection of Cryptococcus antigen in serum and CSF",
    "Indications for Use Summary": "Qualitative or semi-quantitative assay for detection of capsular polysaccharide antigens of Cryptococcus species complex in serum and CSF to aid in the diagnosis of cryptococcosis, used in conjunction with clinical evaluation and other diagnostic procedures",
    "fda_folder": "Microbiology"
}